The company said fourth-quarter sales were $819 million, down 4.5% from $859 million a year earlier, and full-year sales were $2,956 million, down 0.5% from $2,972 million a year earlier.

1. 01

   The company said fourth-quarter sales were $819 million, down 4.5% from $859 million a year earlier, and full-year sales were $2,956 million, down 0.5% from $2,972 million a year earlier.

2. 02

   The company said GAAP diluted earnings per share for the fourth quarter were $3.65 ($3.81 a year earlier), non-GAAP EPS were $3.62 ($3.84 a year earlier), and full-year non-GAAP EPS were $11.75 ($12.02 a year earlier).

3. 03

   The company said instrument system sales in the fourth quarter fell 14% as reported (20% in organic constant currency), recurring revenues rose 7%, Asia sales fell 18%, and China sales fell by almost 40%.

4. 04

   The company guided for full-year 2024 organic constant currency sales growth of 0% to +2% and non-GAAP EPS of $11.75 to $12.05. It also gave reported sales growth for Q1 of -8.5% to -6.5% and non-GAAP EPS of $2.05 to $2.15.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.